具有新化学架构的抗菌药物在临床开发中
Dominik Heimann1, Daniel Kohnhäuser1, Alexandra Jana Kohnhäuser2
1Department of Chemical Biology, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124, Braunschweig, Germany.
Drugs
|January 23, 2025
概括
抗菌素耐药性是一个重大的健康危机. 本次审查强调了正在开发的19种新型抗菌药物,这些药物可以克服耐药性并改善患者的治疗结果.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的全球健康威胁,原因是抗生素疗效降低和新药开发有限.
- 过度使用和滥用当前抗生素加快了耐药细菌菌株的演变,迫切需要治疗创新.
研究的目的:
- 通过突出显示2024年6月临床开发中的19种新型抗菌药物来审查创新疗法.
- 分析具有新化学支架的化合物,分子标或打击抗微生物耐药性的作用机制.
主要方法:
- 在临床开发中的新型抗菌化合物的文献综述.
- 分析科学基础,药学动力学概况和选择抗菌剂的开发状态.
主要成果:
- 在临床试验中确定了19种有前途的新型抗菌剂.
- 通过独特的化学结构,新的点和独特的作用机制来表征这些药物的特征.
结论:
- 创新的抗生素药物开发对于抵消细菌耐药性至关重要.
- 这些新型抗菌药物为克服抗生素治疗现有的局限性和改善治疗结果提供了潜在的解决方案.
相关概念视频
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Antibiotic Selection
52.2K
Overview
52.2K


